![Paul V. Radspinner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul V. Radspinner
Founder at FluGen, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Kevin R. Kozak | M | - |
Co-D Therapeutics, Inc.
![]() Co-D Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Co-D Therapeutics, Inc. operates as a preclinical stage biopharmaceutical firm. Its product, Triolimus, helps treats cancer. The company was founded by Kevin R. Kozak, Glen S. Kwon, and Abdalla A. Saad and is headquartered in Madison, WI. | - |
Abdalla A. Saad | M | - |
Co-D Therapeutics, Inc.
![]() Co-D Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Co-D Therapeutics, Inc. operates as a preclinical stage biopharmaceutical firm. Its product, Triolimus, helps treats cancer. The company was founded by Kevin R. Kozak, Glen S. Kwon, and Abdalla A. Saad and is headquartered in Madison, WI. | - |
C. Boyd Clarke | M | 74 |
FluGen, Inc.
![]() FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | - |
Glen S. Kwon | M | - |
Co-D Therapeutics, Inc.
![]() Co-D Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Co-D Therapeutics, Inc. operates as a preclinical stage biopharmaceutical firm. Its product, Triolimus, helps treats cancer. The company was founded by Kevin R. Kozak, Glen S. Kwon, and Abdalla A. Saad and is headquartered in Madison, WI. | - |
Paul Weiss | M | 66 |
FluGen, Inc.
![]() FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | - |
David G. Walsh | M | - |
FluGen, Inc.
![]() FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | - |
Eric Patzer | M | 75 |
FluGen, Inc.
![]() FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | - |
Pamuk Bilsel | M | - |
FluGen, Inc.
![]() FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | - |
Erik Iverson | M | 56 |
FluGen, Inc.
![]() FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | - |
Alex Kim | M | 56 |
Co-D Therapeutics, Inc.
![]() Co-D Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Co-D Therapeutics, Inc. operates as a preclinical stage biopharmaceutical firm. Its product, Triolimus, helps treats cancer. The company was founded by Kevin R. Kozak, Glen S. Kwon, and Abdalla A. Saad and is headquartered in Madison, WI. | - |
David A. Newberg | M | - |
FluGen, Inc.
![]() FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | - |
J. Patrick Genn | M | - |
Co-D Therapeutics, Inc.
![]() Co-D Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Co-D Therapeutics, Inc. operates as a preclinical stage biopharmaceutical firm. Its product, Triolimus, helps treats cancer. The company was founded by Kevin R. Kozak, Glen S. Kwon, and Abdalla A. Saad and is headquartered in Madison, WI. | - |
Renee Herber | F | - |
FluGen, Inc.
![]() FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | 9 years |
Robert Belshe | M | - |
FluGen, Inc.
![]() FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gabriele Neumann | M | - |
FluGen, Inc.
![]() FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | - |
Yoshihiro Kawaoka | M | - |
FluGen, Inc.
![]() FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 16 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paul V. Radspinner
- Personal Network